NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 3 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding NovaBridge Biosciences changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 49 | +2 |
| Shares | 29.3M | 6.03M | 24.7M | +1.39M (+6.0%) |
| Value | $72.1M | $14.8M | $48.1M | −$9.15M (−16.0%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held NovaBridge Biosciences at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 1,231,946 | $2.40M | 0.00% |
| Two Sigma Investments, LP | 851,348 | $1.66M | 0.00% |
| E Fund Management Co., Ltd. | 589,020 | $1.15M | 0.03% |
| Alps Advisors Inc | 117,096 | $228.3K | 0.00% |
| Headlands Technologies LLC | 65,183 | $127.1K | 0.01% |
| SG Americas Securities, LLC | 38,198 | $74.0K | 0.00% |
| Jane Street Group, LLC | 18,343 | $35.8K | 0.00% |
| Two Sigma Securities, LLC | 15,641 | $30.5K | 0.00% |
| Aigen Investment Management, LP | 11,426 | $22.3K | 0.01% |
| Bronte Capital Management Pty Ltd. | 11,192 | $21.8K | 0.00% |
| Simplex Trading, LLC | 1,967 | $3.83K | 0.00% |
| Group One Trading, L.P. | 143 | $279 | 0.00% |
| Advisor Group Holdings, Inc. | 30 | $58 | 0.00% |
Sold out (11)
Institutions that held NovaBridge Biosciences at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,389,403 | $3.42M |
| HRT Financial LP | 107,524 | $264.0K |
| XTX Topco Ltd | 101,509 | $249.7K |
| Axq Capital, LP | 83,330 | $205.0K |
| Dymon Asia Capital (Singapore) Pte. Ltd. | 80,400 | $197.8K |
| Leonteq Securities AG | 80,000 | $196.8K |
| Schonfeld Strategic Advisors LLC | 35,414 | $87.1K |
| Jump Financial, LLC | 19,833 | $48.8K |
| Bank of Nova Scotia | 11,178 | $27.5K |
| Vermillion Wealth Management, Inc. | 200 | $492 |
| Royal Bank of Canada | 99 | $0 |
Not filed for Q2 2026 yet (1)
Institutions that held NovaBridge Biosciences at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 6,032,650 | $14.8M |